Connor, Clark & Lunn Investment Management (CC&L)’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Sell |
318,005
-433,213
| -58% | -$31.8M | 0.08% | 216 |
|
|
2025
Q1 | $85.8M | Sell |
751,218
-45,577
| -6% | -$5.21M | 0.37% | 50 |
|
|
2024
Q4 | $40.2M | Sell |
796,795
-62,768
| -7% | -$3.16M | 0.18% | 99 |
|
|
2024
Q3 | $39.8M | Buy |
859,563
+143,507
| +20% | +$6.64M | 0.19% | 85 |
|
|
2024
Q2 | $23.3M | Buy |
716,056
+173,878
| +32% | +$5.65M | 0.1% | 169 |
|
|
2024
Q1 | $13.7M | Buy |
542,178
+180,971
| +50% | +$4.56M | 0.06% | 254 |
|
|
2023
Q4 | $11.7M | Sell |
361,207
-1,229
| -0.3% | -$39.9K | 0.05% | 253 |
|
|
2023
Q3 | $9.87M | Sell |
362,436
-472
| -0.1% | -$12.9K | 0.05% | 250 |
|
|
2023
Q2 | $8.07M | Buy |
362,908
+141,896
| +64% | +$3.16M | 0.04% | 300 |
|
|
2023
Q1 | $4.79M | Buy |
221,012
+82,269
| +59% | +$1.78M | 0.03% | 378 |
|
|
2022
Q4 | $2.82M | Buy |
138,743
+56,445
| +69% | +$1.15M | 0.02% | 468 |
|
|
2022
Q3 | $2.11M | Buy |
82,298
+7,634
| +10% | +$196K | 0.01% | 488 |
|
|
2022
Q2 | $1.78M | Sell |
74,664
-62,886
| -46% | -$1.5M | 0.01% | 495 |
|
|
2022
Q1 | $3.1M | Buy |
137,550
+89,449
| +186% | +$2.01M | 0.02% | 406 |
|
|
2021
Q4 | $952K | Buy |
48,101
+36,251
| +306% | +$717K | ﹤0.01% | 686 |
|
|
2021
Q3 | $233K | Buy |
+11,850
| New | +$233K | ﹤0.01% | 924 |
|